| Product Code: ETC7919798 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Latvia Prophylactic Vaccines Market Overview |
3.1 Latvia Country Macro Economic Indicators |
3.2 Latvia Prophylactic Vaccines Market Revenues & Volume, 2021 & 2031F |
3.3 Latvia Prophylactic Vaccines Market - Industry Life Cycle |
3.4 Latvia Prophylactic Vaccines Market - Porter's Five Forces |
3.5 Latvia Prophylactic Vaccines Market Revenues & Volume Share, By Vaccine Type, 2021 & 2031F |
3.6 Latvia Prophylactic Vaccines Market Revenues & Volume Share, By Disease, 2021 & 2031F |
3.7 Latvia Prophylactic Vaccines Market Revenues & Volume Share, By Administration, 2021 & 2031F |
3.8 Latvia Prophylactic Vaccines Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
3.9 Latvia Prophylactic Vaccines Market Revenues & Volume Share, By End-Users, 2021 & 2031F |
4 Latvia Prophylactic Vaccines Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing awareness about the importance of vaccination in Latvia |
4.2.2 Government initiatives to promote vaccination programs |
4.2.3 Growing focus on preventive healthcare measures |
4.3 Market Restraints |
4.3.1 Limited access to healthcare services in certain regions of Latvia |
4.3.2 Vaccine hesitancy among some population groups |
4.3.3 Regulatory challenges and approval processes for new vaccines |
5 Latvia Prophylactic Vaccines Market Trends |
6 Latvia Prophylactic Vaccines Market, By Types |
6.1 Latvia Prophylactic Vaccines Market, By Vaccine Type |
6.1.1 Overview and Analysis |
6.1.2 Latvia Prophylactic Vaccines Market Revenues & Volume, By Vaccine Type, 2021- 2031F |
6.1.3 Latvia Prophylactic Vaccines Market Revenues & Volume, By Live/Attenuated Vaccines, 2021- 2031F |
6.1.4 Latvia Prophylactic Vaccines Market Revenues & Volume, By Inactivated Vaccines, 2021- 2031F |
6.1.5 Latvia Prophylactic Vaccines Market Revenues & Volume, By Subunit Vaccines, 2021- 2031F |
6.1.6 Latvia Prophylactic Vaccines Market Revenues & Volume, By Toxoid Vaccines, 2021- 2031F |
6.1.7 Latvia Prophylactic Vaccines Market Revenues & Volume, By Conjugate Vaccines, 2021- 2031F |
6.1.8 Latvia Prophylactic Vaccines Market Revenues & Volume, By Recombinant Vector Vaccines, 2021- 2031F |
6.2 Latvia Prophylactic Vaccines Market, By Disease |
6.2.1 Overview and Analysis |
6.2.2 Latvia Prophylactic Vaccines Market Revenues & Volume, By Pneumococcal Disease, 2021- 2031F |
6.2.3 Latvia Prophylactic Vaccines Market Revenues & Volume, By Poliovirus, 2021- 2031F |
6.2.4 Latvia Prophylactic Vaccines Market Revenues & Volume, By Hepatitis, 2021- 2031F |
6.2.5 Latvia Prophylactic Vaccines Market Revenues & Volume, By Influenza, 2021- 2031F |
6.2.6 Latvia Prophylactic Vaccines Market Revenues & Volume, By Measles, 2021- 2031F |
6.2.7 Latvia Prophylactic Vaccines Market Revenues & Volume, By Mumps, 2021- 2031F |
6.2.8 Latvia Prophylactic Vaccines Market Revenues & Volume, By Varicella, 2021- 2031F |
6.2.9 Latvia Prophylactic Vaccines Market Revenues & Volume, By Varicella, 2021- 2031F |
6.3 Latvia Prophylactic Vaccines Market, By Administration |
6.3.1 Overview and Analysis |
6.3.2 Latvia Prophylactic Vaccines Market Revenues & Volume, By Intramuscular Route, 2021- 2031F |
6.3.3 Latvia Prophylactic Vaccines Market Revenues & Volume, By Subcutaneous Route, 2021- 2031F |
6.3.4 Latvia Prophylactic Vaccines Market Revenues & Volume, By Oral Route, 2021- 2031F |
6.3.5 Latvia Prophylactic Vaccines Market Revenues & Volume, By Intravenous Injection, 2021- 2031F |
6.3.6 Latvia Prophylactic Vaccines Market Revenues & Volume, By Administration Routes, 2021- 2031F |
6.4 Latvia Prophylactic Vaccines Market, By Distribution Channel |
6.4.1 Overview and Analysis |
6.4.2 Latvia Prophylactic Vaccines Market Revenues & Volume, By Hospital Pharmacy, 2021- 2031F |
6.4.3 Latvia Prophylactic Vaccines Market Revenues & Volume, By Retail Pharmacy and Online Pharmacy, 2021- 2031F |
6.5 Latvia Prophylactic Vaccines Market, By End-Users |
6.5.1 Overview and Analysis |
6.5.2 Latvia Prophylactic Vaccines Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.5.3 Latvia Prophylactic Vaccines Market Revenues & Volume, By Homecare, 2021- 2031F |
6.5.4 Latvia Prophylactic Vaccines Market Revenues & Volume, By Specialty Clinics, 2021- 2031F |
7 Latvia Prophylactic Vaccines Market Import-Export Trade Statistics |
7.1 Latvia Prophylactic Vaccines Market Export to Major Countries |
7.2 Latvia Prophylactic Vaccines Market Imports from Major Countries |
8 Latvia Prophylactic Vaccines Market Key Performance Indicators |
8.1 Immunization coverage rates for key target populations |
8.2 Number of vaccination campaigns conducted annually |
8.3 Percentage of healthcare professionals trained in vaccine administration |
8.4 Research and development investments in new vaccine technologies |
8.5 Public perception and acceptance of vaccines, measured through surveys or polls |
9 Latvia Prophylactic Vaccines Market - Opportunity Assessment |
9.1 Latvia Prophylactic Vaccines Market Opportunity Assessment, By Vaccine Type, 2021 & 2031F |
9.2 Latvia Prophylactic Vaccines Market Opportunity Assessment, By Disease, 2021 & 2031F |
9.3 Latvia Prophylactic Vaccines Market Opportunity Assessment, By Administration, 2021 & 2031F |
9.4 Latvia Prophylactic Vaccines Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
9.5 Latvia Prophylactic Vaccines Market Opportunity Assessment, By End-Users, 2021 & 2031F |
10 Latvia Prophylactic Vaccines Market - Competitive Landscape |
10.1 Latvia Prophylactic Vaccines Market Revenue Share, By Companies, 2024 |
10.2 Latvia Prophylactic Vaccines Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here